Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study
Crossref DOI link: https://doi.org/10.1186/s13075-015-0913-x
Published Online: 2016-01-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bay-Jensen, Anne C.
Platt, Adam
Siebuhr, Anne Sofie
Christiansen, Claus
Byrjalsen, Inger
Karsdal, Morten A.